Hematology Profile of Tuberculosis Lymphadenitis Patients at Siti Rahmah Hospital, Padang, Indonesia

Debie Anggraini, Meta Zulyati Oktora


Tuberculosis (TB) is a progressive granulomatous infectious disease caused by Gram-positive acid-resistant bacilli classified in the genus Mycobacterium. Tuberculosis in humans is caused by Mycobacterium tuberculosis (MTB) and it mainly infects the lungs, although it can also infect intestines, meninges, bones, lymph nodes, skin that cause extra-pulmonary TB. Tuberculous lymphadenitis is an inflammatory process in lymph nodes as a result of MTB activity. The inflammatory process caused by MTB activity is often associated with anemia as the most common complication. Anemia in TB is caused by an inflammatory process associated with bone marrow suppression due to pro-inflammatory cytokines, thus inhibiting the proliferation and differentiation of erythroid progenitor cells. This chronic TB infection also affects iron hemostasis, thus further affecting the hematological profile of TB patients. This study aimed to determine the hematology profile of TB lymphadenitis patients in the Siti Rahmah Hospital, Padang, Indonesia. This was a descriptive study, with a population of patients diagnosed with TB lymphadenitis based on the results of a fine needle biopsy in the Colli region. The samples of this study consisted of 24 patients who have tested the hematology profile. Tuberculosis lymphadenitis patients in females were higher than males, the mean age was 26.75±19.53 years old dominated by an adult (54%). The mean of 3 hemoglobin levels was 11.8±1.522 g/dL, with 62.5% anemia patients. The mean leukocyte count was 10400±3018.926/mm , 3 with 54.2% of patients had normal levels of leukocyte. The mean of thrombocyte count was 334750±74440.668/mm , with 83.3% in normal levels and the mean of Erythrocyte Sedimentation Rate (ESR) was 35.25±31.489 mm/h, with 54.2% patients in high ESR. Hematology profile in TB lymphadenitis patient was anemia, normal levels of leukocytes, thrombocyte, and increased levels of ESR.


Anemia, erythrocyte sedimentation rate, hematology profile, tuberculosis lymphadenitis

Full Text:



Khan MK, Islam MM, Ferdous J, Alam MM. An overview

on epidemiology of tuberculosis. Mymensingh Med J.

; 28(1): 259-266.

Rachmayanti N, Kusmiati T. Diagnostic value of

encode TB IgG and IgM rapid test to support

pulmonary tuberculosis diagnosis. Indones J Clin

Pathol Med Lab, 2020; 26(2): 138-41.

Susanto J, Nugraha J, Soedarsono S. IL-4 level in

rifampicin-sensitive and rifampicin-resistant lung

tuberculosis patients. Indones J Clin Pathol Med Lab,

; 27(1): 46-50.

WHO. Guidelines on tuberculosis infection prevention

and control. WHO, 2019; 91: 1689-99.

de Martino M, Lodi L, Galli L, Chiappini E. Immune

response to Mycobacterium tuberculosis : A narrative

review. Front Pediatr, 2019; 7: 1-8.

Indonesia Health Profile 2018] [Internet]. 2019; 207.

Available from: http://www.depkes.go.id/resources/



-2018 (accessed 9 Sept, 2020).

Zhai W, Wu F, Zhang Y, Fu Y, Liu Z. The immune escape

mechanisms of Mycobacterium tuberculosis. Int. J.

Mol. Sci, 2019; 20: 340.

Howard NC, Khader SA. Immunometabolism during

Mycobacterium tuberculosis infection. Trends

Microbiol [Internet]. 2020; 28(10): 832-50. Available

from: https://doi.org/10.1016/accessed 8 August, 2020).

Angelia E. Angka kejadian tuberkulosis paru dan

ekstra paru pasien rawat jalan di Rumah Sakit

Immanuel. Bandung, 2016; 1-52. (Thesis).

Peddireddy V, Doddam SN, Ahmed N. Mycobacterial

dormancy systems and host responses in tuberculosis.

Front Immunol, 2017; 8: 1-19.

Jee B. Understanding the host immune response

against Mycobacterium tuberculosis infection. Centr

Eur J Immunol, 2020; 45 (1): 99-103.

Gothi D, Spalgais S. Review article lymph node

tuberculosis. EC Pulmonol Respir Med, 2016; 2: 194-211.

Nasution SD. Malnutrisi dan anemia pada penderita

tuberkulosis paru malnutrition and anemia in

tuberculosis patient. J Mayority, 2015; 4: 29-36.

Sharma D, Sarkar D. Pathophysiology of tuberculosis:

An update review. Pharmatutor, 2018; 6(2): 15.

DOI: http://dx.doi.org/10.24293/ijcpml.v27i3.1719


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.